Concepedia

Eyassu Chernet

EC

Statistics

Publications

23

Citations

2.3K

H-Index

20

Active since

1984

Affiliations

Eli Lilly (United States)(Current)

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

Richard L. Roudebush VA Medical Center

National Institute of Mental Health

Eyassu Chernet is an author at Eli Lilly (United States) specializing in neuropharmacology, neuroscience, and neurochemistry.

Publications per year

1984–2020

23

Publications

23

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

Yansheng Du, Zhizhong Ma, Suizhen Lin et al. · Proceedings of the National Academy of Sciences · 2001 · 786 citations · Full text

, , +17

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

Frank P. Bymaster, Wei Zhang, Petra A. Carter et al. · Psychopharmacology · 2002 · 334 citations

, , +16

Densities of dopamine D2 receptors are reduced in CNS regions of alcohol-preferring P rats

William J. McBride, Eyassu Chernet, Wanda Dyr et al. · Alcohol · 1993 · 164 citations

, , +12

Ethanol and negative feedback regulation of mesolimbic dopamine release in rats

R. Kohl, Jason Katner, Eyassu Chernet et al. · Psychopharmacology · 1998 · 123 citations

, , +14

The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain

Fumihiko Yasuno, Amira K. Brown, Sami S. Zoghbi et al. · Neuropsychopharmacology · 2007 · 86 citations

, , +5

1–5 of 23